AI-071

N/A

Report date: 2025/02/25 11:39:31

Base Information

Drug NameAI-071
Drug Alias NameAI-071
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionSialic acid binding immunoglobulin-like lectins agonists
TargetsSialic acid binding immunoglobulin-like lectins
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPreclinical
Originator CompaniesAcroImmune Group
China Registration ClassN/A

Develop Information

Active CompaniesAcroImmune Group
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A